U.S. Paper and Forestry Products Stock News

Analyst commentary has recently highlighted Newmark Group (NMRK) as undervalued relative to peers, pointing to supportive valuation metrics and a favorable earnings outlook that together are drawing fresh attention to the stock. See our latest analysis for Newmark Group. Recent trading has been relatively steady, with Newmark Group's share price at $14.87 and a 90-day share price return of 2.20%. Its 1-year total shareholder return of 34.52% reflects momentum that has built over a longer...

SNAP restrictions on sugary and highly processed foods are putting fresh attention on health and wellness food stocks, as billions in assisted grocery spending are reconsidered. For investors, this kind of policy shift can change which companies benefit from consumer demand tied to assistance programs and which feel pressure on sales of less nutritious products. This article looks at 3 stocks from a Health and Wellness Food Companies screener that appear more aligned with cleaner labels and...

BioLife Solutions (BLFS) is back in focus after Prosper Stars & Stripes added the stock to its portfolio again, pointing to the company’s renewed emphasis on core biopreservation media as well as cell and gene therapy exposure. See our latest analysis for BioLife Solutions. Recent trading reflects that shift in attention, with BioLife Solutions showing a 35.84% 90 day share price return and a 22.71% 1 year total shareholder return, while the current share price sits at $26.04 as investors...

Cytokinetics has entered a new phase as a commercial-stage biotech after securing FDA and European Commission approvals for Myqorzo, its first marketed therapy for symptomatic obstructive hypertrophic cardiomyopathy, and beginning its U.S. launch. An important implication is that Cytokinetics now shifts from being purely development-focused to also managing real-world product uptake, reimbursement, and regional rollouts, which can materially reshape its operating profile and risk mix. With...

Skyworks Solutions (SWKS) is back in focus after quarterly revenue and EPS both beat analyst estimates, with CEO Phil Brace pointing to solid execution and improving momentum across the company’s product portfolio as key drivers. See our latest analysis for Skyworks Solutions. At a share price of $72.45, Skyworks Solutions has seen a 32.96% 90 day share price return and a 12.51% year to date share price return, while the 5 year total shareholder return is down 53.17%. This suggests that...

Argan (AGX) is back on investors’ radar after record first quarter fiscal 2027 results highlighted revenue and earnings growth from energy infrastructure projects, along with a fresh quarterly dividend declaration that underscores ongoing shareholder return plans. See our latest analysis for Argan. The latest quarterly update and dividend news arrive alongside a sharp shift in market sentiment, with Argan’s 90 day share price return of 59.53% and year to date share price return of 126.67%...

AI is no longer just a story about experiments and cash burn; it is increasingly about companies that turn heavy AI investment into real earnings. With inflation, rates, and energy prices all in focus, many investors are looking for businesses that already know how to convert AI spending into profits instead of promises. The Profitable AI Stocks screener is built for this, highlighting companies that are not only serious about AI but are also earning from it. In this article, you will see 3...

With inflation trends and central bank policies pulling markets in different directions, many investors are looking for a steadier source of portfolio income. That is where high yield dividend stocks come in. The Dividend Powerhouses screener focuses on companies with yields above 5% that are described as well covered, growing and stable, offering a rules based way to focus on income payers rather than chasing headlines. In this article, you will see three stocks from this screener that stand...

Clinical PSMA Data Sparks Fresh Look At Vir Biotechnology Stock Vir Biotechnology (VIR) has moved back onto investors' radars after new PSMA clinical data in prostate cancer prompted an updated investment thesis and renewed focus on the company’s T cell engager pipeline. See our latest analysis for Vir Biotechnology. At a share price of US$9.16, Vir Biotechnology’s short term picture reflects a mix of optimism and caution, with a 7 day share price return of 6.39% and a year to date share...

Starwood Property Trust, Inc. previously declared a quarterly dividend of US$0.48 per common share for the period ended June 30, 2026, payable on July 15, 2026 to shareholders of record as of June 30, 2026. While this payout supports the company's income-oriented profile, its very large payout ratio versus earnings raises questions about how comfortably future dividends can be supported. Next, we’ll examine how this US$0.48 dividend declaration, and the questions around its coverage,...

Recently, Hilton Worldwide Holdings reported double-digit year-over-year growth in both revenue and net profit and continued to be recognized for its solid financial position within the Hotels & Entertainment Services industry, while institutional investors increased their aggregate holdings to slightly above the company’s total free float. At the same time, institutional ownership reached the highest score in its industry and Hilton launched a large-scale mentorship and travel-points...

Synovis Micro Companies Alliance, a subsidiary of Baxter International (BAX), has signed an exclusive multi-year deal with MediThinQ to distribute the SHIYA 3D surgical visualization platform globally, expanding Baxter’s footprint in digital surgical technology. See our latest analysis for Baxter International. The MediThinQ agreement arrives after a volatile stretch for Baxter International, with a 19.75% 90 day share price return contrasting with a 33.11% decline in 1 year total shareholder...

Acuity is approaching its Q3 earnings release, with analysts previously expecting a slight year-on-year earnings-per-share increase and modest overall revenue growth, driven by differing trajectories across its segments. Expectations that Acuity Intelligent Spaces could grow meaningfully while Acuity Brands Lighting contracts highlight how the company’s mix shift may influence investor focus and risk assessments. We’ll now explore how the anticipated strength in Acuity Intelligent Spaces,...

SEI Investments (NasdaqGS:SEIC) has created new executive roles to scale its AI and data strategy across the enterprise. The company appointed Matt Provencher as Global Head of Enterprise Professional Services to lead its expanded services organization. SEI is rolling out next generation platforms, AI powered tools, and enterprise wide automation initiatives to support clients. SEI Investments operates at the intersection of technology and investment services, providing platforms and...

Kymera Therapeutics (KYMR) is back in focus after sharing new data on its protein degrader pipeline, including Phase 1 results for KT-621 in healthy Japanese adults and expanded preclinical findings for lupus candidate KT-579. See our latest analysis for Kymera Therapeutics. Kymera Therapeutics’ recent KT-621 and KT-579 readouts arrive after a period of strong momentum, with the latest share price at $90.43, a 30 day share price return of 14.63% and a one year total shareholder return of...

ADT Inc. recently earned two 2026 ConsumerAffairs Buyer’s Choice Awards for Best Customer Service and Best Product Offering, launched its new self-installed ADT Blu home security system, and joined the Board of Directors of the Connectivity Standards Alliance alongside major technology firms. This combination of third-party recognition, a flexible DIY product launch, and a deeper role in shaping smart home standards underscores how ADT is positioning itself at the center of evolving home...

Earlier in June 2026, American Express completed a €750 million fixed-to-floating rate, callable senior Eurobond offering due June 16, 2034, with Merrill Lynch International, Deutsche Bank AG London, and Morgan Stanley & Co. International acting as co-lead underwriters. This bond issuance, alongside moves such as the planned €700 million cash acquisition of TheFork and a new global NFL partnership, highlights how American Express is using its balance sheet and brand to expand fee-based,...

In June 2026, Viking Therapeutics appointed Hubert C. Chen, M.D., as chief medical officer to lead its clinical, medical, and regulatory functions under CEO Brian Lian. Dr. Chen’s background in obesity, type 2 diabetes, and regulatory strategy for successful drug approvals directly aligns with Viking’s focus on VK2735 and broader metabolic programs. Now we’ll explore how Dr. Chen’s arrival as chief medical officer could shape Viking Therapeutics’ investment narrative around obesity...

Earlier this month, Navitas Semiconductor introduced its UHV-TO-247-4-ISO package for 1,200 V to 3,300 V GeneSiC SiC MOSFETs, combining over 12 mm creepage, more than 6,000 V integrated isolation, and improved thermal and EMI characteristics in a discrete form factor for grid, energy storage, renewables, and AI data-center power systems. By integrating an Aluminum Nitride substrate and reflow-compatible, directly cooled heatsink interface, the new package aims to simplify high-voltage system...

In recent months, Assured Guaranty has faced operational pressures, including lower net premiums earned, projections for substantially reduced revenue, and a two-year decline in earnings per share. These trends point to sustained challenges in its core credit protection business, raising questions about how effectively the company can sustain its existing earnings profile. We’ll now examine how these operational challenges and weaker earnings trends may alter Assured Guaranty’s earlier...

Recently, Marriott Vacations Worldwide reported quarterly revenue of US$827 million and a year-on-year net profit increase of 60.71%, alongside a slightly improved financial health score of 6.52 that still leaves it in the lower tier of its industry. At the same time, institutional ownership rose strongly, with institutions now holding a higher share of the company and Hotchkis & Wiley emerging as the largest holder at about 2.89% of shares outstanding, suggesting growing professional...

Charles River Laboratories International stock reacts to new AI drug discovery collaboration Charles River Laboratories International (CRL) is back in focus after a Morgan Stanley upgrade and a new collaboration with Eli Lilly's AI and machine learning drug discovery platform, TuneLab. See our latest analysis for Charles River Laboratories International. The recent Morgan Stanley upgrade and the Lilly TuneLab collaboration arrive as momentum in Charles River Laboratories International’s share...

Vaxcyte (PCVX) recently started dosing participants in a Phase 1 trial of VAX-A1, its investigational Group A Streptococcus vaccine. This development gives investors a fresh clinical milestone to weigh alongside the stock’s recent performance. See our latest analysis for Vaxcyte. The recent VAX-A1 trial news comes as Vaxcyte’s 7-day share price return of 8.39% and 30-day share price return of 8.75% contrast with a softer 90-day share price return. The 1-year total shareholder return of 56.50%...

In recent days, Victory Capital Holdings reported very high institutional ownership of 95.08%, a strong quarter-over-quarter increase, alongside solid financial health supported by higher quarterly revenue and net profit despite lower operating efficiency. Technical indicators now show the stock trading between clearly defined support and resistance levels with multiple buy signals, highlighting growing institutional confidence combined with active range-based trading interest. We’ll now...